Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Riva

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 1999
Loco-regional radioimmunotherapy of high-grade malignant gliomas using specific monoclonal antibodies labeled with 90Y: a phase I studyP Riva, G Franceschi, M Frattarelli, et al.
Thrombosis and Haemostasis|June 6, 2014
Poor predictive value of contemporary bleeding risk scores during long-term treatment of venous thromboembolism. A multicentre retrospective cohort studyN Riva, M Bellesini, M N D Di Minno, et al.
British Journal of Cancer|May 9, 2007
A multicentre phase II study of carboplatin plus pegylated liposomal doxorubicin as first-line chemotherapy for patients with advanced or recurrent endometrial carcinoma: the END-1 study of the MITO (Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies) groupS Pignata, G Scambia, C Pisano, et al.
Journal of Thrombosis and Haemostasis : JTH|August 29, 2012
Safety and efficacy of low-dose fondaparinux (1.5 mg) for the prevention of venous thromboembolism in acutely ill medical patients with renal impairment: the FONDAIR studyW Ageno, N Riva, P Noris, et al.
European Journal of Neurology|February 24, 2017
Meditation training for people with amyotrophic lateral sclerosis: a randomized clinical trialF Pagnini, A Marconi, A Tagliaferri, et al.
Journal of Thrombosis and Haemostasis : JTH|May 22, 2026
Splanchnic vein thrombosis with and without myeloproliferative neoplasms: a comparative cohort studyA K Ko, L Milana, N Riva, et al.
Journal of Clinical Epidemiology|June 6, 2021
Resource use during systematic review production varies widely: a scoping reviewB Nussbaumer-Streit, M Ellen, I Klerings, et al.
European Journal of Neurology|March 8, 2018
Cardiovascular diseases may play a negative role in the prognosis of amyotrophic lateral sclerosisJ Mandrioli, L Ferri, A Fasano, et al.
ESMO Open|March 16, 2024
REGOMA-OSS: a large, Italian, multicenter, prospective, observational study evaluating the efficacy and safety of regorafenib in patients with recurrent glioblastomaM Caccese, I Desideri, V Villani, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 1999
Loco-regional radioimmunotherapy of high-grade malignant gliomas using specific monoclonal antibodies labeled with 90Y: a phase I studyP Riva, G Franceschi, M Frattarelli, et al.
Thrombosis and Haemostasis|June 6, 2014
Poor predictive value of contemporary bleeding risk scores during long-term treatment of venous thromboembolism. A multicentre retrospective cohort studyN Riva, M Bellesini, M N D Di Minno, et al.
British Journal of Cancer|May 9, 2007
A multicentre phase II study of carboplatin plus pegylated liposomal doxorubicin as first-line chemotherapy for patients with advanced or recurrent endometrial carcinoma: the END-1 study of the MITO (Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies) groupS Pignata, G Scambia, C Pisano, et al.
Journal of Thrombosis and Haemostasis : JTH|August 29, 2012
Safety and efficacy of low-dose fondaparinux (1.5 mg) for the prevention of venous thromboembolism in acutely ill medical patients with renal impairment: the FONDAIR studyW Ageno, N Riva, P Noris, et al.
European Journal of Neurology|February 24, 2017
Meditation training for people with amyotrophic lateral sclerosis: a randomized clinical trialF Pagnini, A Marconi, A Tagliaferri, et al.
Journal of Thrombosis and Haemostasis : JTH|May 22, 2026
Splanchnic vein thrombosis with and without myeloproliferative neoplasms: a comparative cohort studyA K Ko, L Milana, N Riva, et al.
Journal of Clinical Epidemiology|June 6, 2021
Resource use during systematic review production varies widely: a scoping reviewB Nussbaumer-Streit, M Ellen, I Klerings, et al.
European Journal of Neurology|March 8, 2018
Cardiovascular diseases may play a negative role in the prognosis of amyotrophic lateral sclerosisJ Mandrioli, L Ferri, A Fasano, et al.
ESMO Open|March 16, 2024
REGOMA-OSS: a large, Italian, multicenter, prospective, observational study evaluating the efficacy and safety of regorafenib in patients with recurrent glioblastomaM Caccese, I Desideri, V Villani, et al.
Pageof 4